
Regain control with DBS therapy.
See if you or a loved one is a candidate for Medtronic deep brain stimulation (DBS) for Parkinson’s disease.
For someone living with Parkinson’s disease, everyday tasks like holding a cup of coffee can feel out of reach. For over 30 years Medtronic has transformed the lives of over 185,000 people with Parkinson’s disease and other neurological disorders with deep brain stimulation therapy.1
Deep brain stimulation (DBS) is a safe and effective treatment that helps people living with Parkinson’s improve motor symptom control like tremor, slowness, and stiffness.
95% of patients are satisfied with their DBS treatment.†,2
Experience better motor control, more good movement hours, and reduced medications and their side effects.3,4
DBS works 24/7, ensuring symptom control even while you sleep.
DBS therapy can be adjusted to your needs. It can also be removed, if needed.
Discover the only DBS system that automatically adjusts therapy to provide simplified and personalized symptom control.
– Louis, DBS patient
– Lisa, DBS patient
– Andy, DBS patient
Always be sure to talk to your physician about the risks and benefits of DBS therapy.
Not everyone who receives DBS therapy will receive the same results.
As the originator and world leader in deep brain stimulation (DBS), for over 30 years, Medtronic has served over 185,000 patients across our indications in more than 70 countries with our life-changing DBS therapy.1
Over
185,000
patients
served1
DBS therapy is covered by most insurance plans, including Medicare. Your care team will work with you to navigate the insurance process and ensure you get the care you need.
Attend a free informational event to learn from a Medtronic-trained doctor and ask your questions.
† Based on a phone survey of n=38 DBS patients implanted between 1999–2007 to assess patient satisfaction with DBS therapy.
‡ The sensing feature of the Percept ™ PC and Percept ™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status.
§ For median energy use in DBS for Parkinson's disease patients, with moderate (up to two months per year) BrainSense™ technology usage.